- Home
- ILPT vs BNTC Comparison
ILPT vs BNTC Comparison
Compare ILPT & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILPT
- BNTC
- Stock Information
- Founded
- ILPT 2017
- BNTC 1995
- Country
- ILPT United States
- BNTC United States
- Employees
- ILPT N/A
- BNTC N/A
- Industry
- ILPT Real Estate Investment Trusts
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- ILPT Real Estate
- BNTC Health Care
- Exchange
- ILPT Nasdaq
- BNTC Nasdaq
- Market Cap
- ILPT 262.6M
- BNTC 255.9M
- IPO Year
- ILPT 2018
- BNTC N/A
- Fundamental
- Price
- ILPT $3.81
- BNTC $11.30
- Analyst Decision
- ILPT Buy
- BNTC Strong Buy
- Analyst Count
- ILPT 2
- BNTC 7
- Target Price
- ILPT $10.00
- BNTC $24.43
- AVG Volume (30 Days)
- ILPT 244.4K
- BNTC 24.1K
- Earning Date
- ILPT 02-18-2025
- BNTC 02-14-2025
- Dividend Yield
- ILPT 1.05%
- BNTC N/A
- EPS Growth
- ILPT N/A
- BNTC N/A
- EPS
- ILPT N/A
- BNTC N/A
- Revenue
- ILPT $442,322,000.00
- BNTC N/A
- Revenue This Year
- ILPT N/A
- BNTC N/A
- Revenue Next Year
- ILPT $6.87
- BNTC N/A
- P/E Ratio
- ILPT N/A
- BNTC N/A
- Revenue Growth
- ILPT 1.14
- BNTC N/A
- 52 Week Low
- ILPT $3.15
- BNTC $3.66
- 52 Week High
- ILPT $5.45
- BNTC $13.29
- Technical
- Relative Strength Index (RSI)
- ILPT 47.06
- BNTC 52.38
- Support Level
- ILPT $3.84
- BNTC $10.92
- Resistance Level
- ILPT $4.08
- BNTC $11.65
- Average True Range (ATR)
- ILPT 0.14
- BNTC 0.70
- MACD
- ILPT -0.02
- BNTC 0.06
- Stochastic Oscillator
- ILPT 24.21
- BNTC 61.54
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.